Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.700
+0.010 (0.37%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Ovid Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -17.41 | -26.43 | -52.34 | -54.17 | 122.83 | |
| Depreciation & Amortization | 0.27 | 0.61 | 0.57 | 1.38 | 0.24 | |
| Asset Writedown & Restructuring Costs | - | - | - | - | 7.3 | |
| Loss (Gain) From Sale of Investments | -21.05 | -3.35 | -2 | 0.45 | - | |
| Stock-Based Compensation | 4.81 | 6.28 | 7.29 | 6.56 | 5.05 | |
| Other Operating Activities | -0.84 | -32.91 | -1.68 | -1.22 | - | |
| Change in Accounts Payable | -1.23 | -0.51 | 1.75 | -5.17 | 1.7 | |
| Change in Unearned Revenue | - | - | - | - | -12.38 | |
| Change in Other Net Operating Assets | -2.87 | 0.36 | 0.64 | -3.06 | -6.13 | |
| Operating Cash Flow | -38.33 | -55.96 | -45.78 | -55.23 | 118.61 | |
| Capital Expenditures | - | -0.07 | -0.04 | -1.22 | -0.18 | |
| Sale (Purchase) of Intangibles | - | -0.09 | -0.1 | -0.19 | -0.01 | |
| Investment in Securities | -49.85 | 54.75 | -2.44 | -85.46 | -1.63 | |
| Other Investing Activities | - | 0 | -0 | -1 | - | |
| Investing Cash Flow | -49.85 | 54.59 | -2.58 | -87.88 | -1.82 | |
| Issuance of Common Stock | 75.21 | 0.62 | 0.54 | 0.18 | 0.93 | |
| Other Financing Activities | - | - | 30 | - | -0.02 | |
| Financing Cash Flow | 75.21 | 0.62 | 30.54 | 0.18 | 0.9 | |
| Foreign Exchange Rate Adjustments | -0.17 | - | - | - | - | |
| Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - | |
| Net Cash Flow | -13.15 | -0.74 | -17.83 | -142.93 | 117.69 | |
| Free Cash Flow | -38.33 | -56.03 | -45.82 | -56.45 | 118.43 | |
| Free Cash Flow Margin | -528.60% | -9898.76% | -11689.03% | -3756.55% | 56.83% | |
| Free Cash Flow Per Share | -0.52 | -0.79 | -0.65 | -0.80 | 1.74 | |
| Levered Free Cash Flow | -25.64 | -29.9 | -25.89 | -36.24 | 75.6 | |
| Unlevered Free Cash Flow | -25.64 | -29.9 | -25.89 | -36.24 | 75.6 | |
| Change in Working Capital | -4.1 | -0.15 | 2.39 | -8.23 | -16.81 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.